Shanghai Titan Scientific Co.,Ltd.

Shanghai Stock Exchange 688133.SS

Shanghai Titan Scientific Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.38

Shanghai Titan Scientific Co.,Ltd. Debt to Equity Ratio is 0.38 for the year ending December 31, 2023, a 22.68% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Shanghai Titan Scientific Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.31, a 5.21% change year over year.
Shanghai Titan Scientific Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.29, a 126.99% change year over year.
Shanghai Titan Scientific Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.13, a -57.63% change year over year.
Shanghai Titan Scientific Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.31, a -3.17% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

Shanghai Stock Exchange: 688133.SS

Shanghai Titan Scientific Co.,Ltd.

CEO	Mr. Qing Zhang
IPO Date	Oct. 30, 2020
Location	China
Headquarters	No. 89, Shilong Road
Employees	1,637
Sector	Materials
Industries Chemicals & Advanced Materials Biotechnology Research & Consulting

Description

Shanghai Titan Scientific Co., Ltd. provides laboratory products and supporting services for scientific researchers and quality control personnel. It offers a range of services for laboratories in the fields of biomedicine, new materials, new energy, chemical chemistry, fine chemicals, food daily chemicals, analysis, and testing through independent research and development, brand operation, brand agency, integrated packaging services, etc. Shanghai Titan Scientific Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.

Key trends

Past 5 years